Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Return on Equity (2016 - 2022)

Edesa Biotech's Return on Equity history spans 9 years, with the latest figure at 1.33% for Q2 2022.

  • For Q2 2022, Return on Equity fell 54.0% year-over-year to 1.33%; the TTM value through Jun 2022 reached 1.33%, down 54.0%, while the annual FY2021 figure was 1.36%, 11.0% down from the prior year.
  • Return on Equity for Q2 2022 was 1.33% at Edesa Biotech, down from 1.32% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.63% in Q4 2019 and bottomed at 1.42% in Q3 2020.
  • The 5-year median for Return on Equity is 1.13% (2018), against an average of 1.08%.
  • The largest annual shift saw Return on Equity surged 55bps in 2019 before it plummeted -76bps in 2020.
  • A 5-year view of Return on Equity shows it stood at 1.18% in 2018, then surged by 47bps to 0.63% in 2019, then tumbled by -120bps to 1.39% in 2020, then increased by 3bps to 1.34% in 2021, then increased by 1bps to 1.33% in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Return on Equity are 1.33% (Q2 2022), 1.32% (Q1 2022), and 1.34% (Q4 2021).